• Scientist In her lab

    SWHR promotes the analysis of research data for biological and ethnic differences

  • SWHR-Breakfast-10-29-14-0776111

    SWHR Leads Breakfast Briefing on What Women Want in Breast Cancer Screening

  • NewsletterVersion_Draft2

  • Slider4

    SWHR works with researchers and clinicians to advance the field of sex-based biology.

  • Slider3

    SWHR creates initiatives to improve understanding about women’s sleep health.

SWHR Releases Groundbreaking Survey on What Women Want in Breast Cancer Screening 

A New Survey from the Society for Women’s Health Research Reveals Cost and Lack of Insurance Are Biggest Barriers to Mammograms; A Majority of Women Are Unaware the ACA Requires Mammography Screenings at No Cost Sharing.
Read the Press Release.
Read the Executive Summary.
Read the Survey Fact Sheet.

swhr updates

9f95a780-2a8f-4cd4-a9ed-602f21610fb6 Press Releases

SWHR END OF YEAR UPDATE

Posted on 23 December 2014

2014 has proven to be yet another successful year! As it comes to a close, SWHR would be remiss not to reflect on what has been an incredible year.

wenger_150w Press Releases

Former SWHR Board Member & Chair Wins Prestigious Award from American College of Cardiology

Posted on 22 December 2014

Nanette K. Wenger, MD, MACC, MACP, FAHA, Professor of Medicine (Cardiology) Emeritus Emory University School of Medicine, Consultant to the Emory Heart and Vascular Center, and former SWHR Board Member and Chair of the Award has received the 2015 Bernadine Healy Leadership in Women’s CV Disease Award from the Awards Committee and Board of Trustees of the American College of Cardiology.

1258732_43229381 Press Releases

FDA Releases Data Showing Women and Minorities Are Not Studied Enough in Medical Research

Posted on 21 November 2014

Washington, D.C.—The U.S. Food and Drug Administration (FDA) released data today on a dedicated website from six studies reflecting a two-month period in response to a requirement under the “FDA Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data” to make transparent the percentage of female and minority participation in clinical trials for medications intended for all populations. “I am pleased by this action step by FDA,” said Phyllis Greenberger, President and CEO of the Society for Women’s Health Research (SWHR®), “but the news is discouraging. The data validates the concern we have expressed to the FDA for 25 years.”